These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
112 related articles for article (PubMed ID: 21113202)
21. Poly(ADP-ribose)polymerase inhibitor can attenuate the neuronal death after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity in mice. Yokoyama H; Kuroiwa H; Tsukada T; Uchida H; Kato H; Araki T J Neurosci Res; 2010 May; 88(7):1522-36. PubMed ID: 19998477 [TBL] [Abstract][Full Text] [Related]
22. Poly(ADP-ribose) polymerase-1 inhibitor 3-aminobenzamide enhances apoptosis induction by platinum complexes in cisplatin-resistant tumor cells. Nguewa PA; Fuertes MA; Cepeda V; Alonso C; Quevedo C; Soto M; Pérez JM Med Chem; 2006 Jan; 2(1):47-53. PubMed ID: 16787355 [TBL] [Abstract][Full Text] [Related]
23. Poly (ADP-Ribose) polymerase inhibition attenuates atherosclerotic plaque development in ApoE-/- mice with hyperhomocysteinemia. Xie JJ; Yu X; Liao YH; Chen J; Yao R; Chen Y; Liao MY; Ding YJ; Tang TT; Cheng X J Atheroscler Thromb; 2009 Oct; 16(5):641-53. PubMed ID: 19776495 [TBL] [Abstract][Full Text] [Related]
24. Deleterious poly(ADP-ribose)polymerase-1 pathway activation in traumatic brain injury in rat. Besson VC; Croci N; Boulu RG; Plotkine M; Marchand-Verrecchia C Brain Res; 2003 Oct; 989(1):58-66. PubMed ID: 14519512 [TBL] [Abstract][Full Text] [Related]
25. Post-treatment at 12 or 18 hours with 3-aminobenzamide ameliorates retinal ischemia-reperfusion damage. Chiang SK; Lam TT Invest Ophthalmol Vis Sci; 2000 Sep; 41(10):3210-4. PubMed ID: 10967085 [TBL] [Abstract][Full Text] [Related]
26. Effects of Poly (ADP-ribose) Polymerase Inhibition on DNA Integrity and Gene Expression in Ovarian Follicular Cells in Mice with Endotoxemia. Kondratska O; Grushka N; Pavlovych S; Krasutska N; Tsyhankov S; Yanchii R Iran Biomed J; 2022 Jan; 26(1):44-52. PubMed ID: 34826885 [TBL] [Abstract][Full Text] [Related]
27. Myocardial ischemic preconditioning in rodents is dependent on poly (ADP-ribose) synthetase. Liaudet L; Yang Z; Al-Affar EB; Szabó C Mol Med; 2001 Jun; 7(6):406-17. PubMed ID: 11474134 [TBL] [Abstract][Full Text] [Related]
28. Poly(ADP-ribose) polymerase inhibition suppresses inflammation and promotes recovery from adrenal injury in a rat model of acute necrotizing pancreatitis. Yu J; Zuo T; Deng W; Shi Q; Ma P; Chen C; Zhao L; Zhao K; Wang W BMC Gastroenterol; 2016 Jul; 16(1):81. PubMed ID: 27465581 [TBL] [Abstract][Full Text] [Related]
29. Diabetes-induced overexpression of endothelin-1 and endothelin receptors in the rat renal cortex is mediated via poly(ADP-ribose) polymerase activation. Minchenko AG; Stevens MJ; White L; Abatan OI; Komjáti K; Pacher P; Szabó C; Obrosova IG FASEB J; 2003 Aug; 17(11):1514-6. PubMed ID: 12824290 [TBL] [Abstract][Full Text] [Related]
30. Meningitis-associated central nervous system complications are mediated by the activation of poly(ADP-ribose) polymerase. Koedel U; Winkler F; Angele B; Fontana A; Pfister HW J Cereb Blood Flow Metab; 2002 Jan; 22(1):39-49. PubMed ID: 11807392 [TBL] [Abstract][Full Text] [Related]
31. Poly (adp-ribose) polymerase inhibitors as potential therapeutic agents in stroke and neurotrauma. Komjáti K; Besson VC; Szabó C Curr Drug Targets CNS Neurol Disord; 2005 Apr; 4(2):179-94. PubMed ID: 15857303 [TBL] [Abstract][Full Text] [Related]
33. Inhibition of poly(ADP-ribose) polymerase (PARP) influences the mode of sulfur mustard (SM)-induced cell death in HaCaT cells. Kehe K; Raithel K; Kreppel H; Jochum M; Worek F; Thiermann H Arch Toxicol; 2008 Jul; 82(7):461-70. PubMed ID: 18046540 [TBL] [Abstract][Full Text] [Related]
34. Role of poly(ADP-ribose)polymerase in cisplatin-induced injury in LLC-PK1 cells. Shino Y; Itoh Y; Kubota T; Yano T; Sendo T; Oishi R Free Radic Biol Med; 2003 Oct; 35(8):966-77. PubMed ID: 14556861 [TBL] [Abstract][Full Text] [Related]
35. Poly(ADP-ribose) polymerase-independent potentiation of nitrosourea cytotoxicity by 3-aminobenzamide in human malignant glioma cells. Winter S; Weller M Eur J Pharmacol; 2000 Jun; 398(2):177-83. PubMed ID: 10854828 [TBL] [Abstract][Full Text] [Related]
36. Structure and function of poly(ADP-ribose) polymerase-1: role in oxidative stress-related pathologies. Virág L Curr Vasc Pharmacol; 2005 Jul; 3(3):209-14. PubMed ID: 16026317 [TBL] [Abstract][Full Text] [Related]
37. PARP inhibition treatment in a nonconventional experimental mouse model of chronic asthma. Zaffini R; Di Paola R; Cuzzocrea S; Menegazzi M Naunyn Schmiedebergs Arch Pharmacol; 2016 Dec; 389(12):1301-1313. PubMed ID: 27604227 [TBL] [Abstract][Full Text] [Related]
38. Inhibition of poly(adp-ribose) polymerase reduces cardiomyocytic apoptosis after global cardiac arrest under cardiopulmonary bypass. Yeh CH; Chen TP; Lee CH; Wu YC; Lin YM; Jing Lin P Shock; 2006 Feb; 25(2):168-75. PubMed ID: 16525356 [TBL] [Abstract][Full Text] [Related]
39. Inhibitors of poly(ADP-ribose) polymerase modulate signal transduction pathways and the development of bleomycin-induced lung injury. Genovese T; Mazzon E; Di Paola R; Muià C; Threadgill MD; Caputi AP; Thiemermann C; Cuzzocrea S J Pharmacol Exp Ther; 2005 May; 313(2):529-38. PubMed ID: 15644425 [TBL] [Abstract][Full Text] [Related]
40. [THE EFFECT OF OF POLY(ADP-RIBOSE) POLYMERASE INHIBITOR 4-HYDROXY-QUINAZOLINE ON DEATH OF IMMUNE CELLS UNDER IMMUNE COMPLEX-MEDIATED INJURY IN MICE]. Grushka NG Fiziol Zh (1994); 2017; 63(1):43-50. PubMed ID: 29975827 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]